Tag:
Biotechnology Value Fund
Latest Headlines
Latest Headlines
Avigen chops execs and readies liquidation plan
After battling a tender offer from a major shareholder, Avigen announced today that it will liquidate the company barring a shareholder vote to dump its board and replace it with a slate of directors
BVF urges stakeholders to dump Avigen board
Biotechnology Value Fund, which holds a 30 percent stake in Avigen, will finally get that special shareholders meeting it's been pushing for later this month. The firm is urging fellow stockholders
Avigen rejects BVF takeover offer
Avigen has rejected a potential merger deal Biotechnology Value Fund (BVF). Late last month BFV offered $20.9 million for Avigen, which has been in a tough position since October when a mid-stage
